New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Ventas, Inc.

VTR

Real Estate Reit Healthcare Facilities

Ventas, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, up 18.5% from fiscal 2024.

Revenue
+23.0%
EPS
−7.14%
Free cash flow
+20.5%
Total debt
−1.07%

Quarter to September 2026, against a year earlier

86.57 0.43 −0.49%

After hours trading: 86.55, down 0.02%, last trade 7:28pm Eastern.

Market cap
$47.0B
P/E
160×
Fwd P/E FY26e
169×
Dividend yield
2.36%
F-score
7/9
ROIC
2.02%
Net debt / EBITDA
5.5×
Payout ratio
3.8×

Ventas, Inc. (VTR) EBITDA

Alert me on EBITDA

Ventas, Inc.'s EBITDA for fiscal 2025 was $2.2B, up 16.7% from $1.9B in fiscal 2024. Over the twelve months to Sep 30, 2026 it was $2.5B. Over the past ten years it has ranged from $1.5B (fiscal 2021) to $2.2B (fiscal 2025) — the current reading is the highest in ten years. EBITDA has risen for 4 consecutive fiscal years. Ventas, Inc. ranks 2nd of 17 Reit Healthcare Facilities companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $2.2B 16.73%
FY2024 $1.9B 9.12%
FY2023 $1.8B 6.04%
FY2022 $1.7B 7.29%
FY2021 $1.5B (9.77%)
FY2020 $1.7B (11.11%)
FY2019 $1.9B 1.15%
FY2018 $1.9B (2.62%)
FY2017 $1.9B 4.46%
FY2016 $1.9B 3.07%

Quarterly newest first

Period EBITDA Change
Sep 2026 $680.0M 5.73%
Jun 2026 $643.2M 7.98%
Mar 2026 $595.6M 1.08%
Dec 2025 $589.2M 2.39%
43 more quarters

Against its own ten years

Low $1.5B High $2.2B
Ten-year median $1.9B
Current reading's percentile 100

EBITDA against peers

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on VTR